Jefferies Provides Color on Becton, Dickinson and Co., Buy

Jefferies provided color on Becton, Dickinson and Co. BDX. In a research report published today, Jefferies stressed strong performances of the company's Biosciences and Diagnostics units as the driver of the company's revenues. In the report, Jefferies states, "The outlook for both its Biosciences and Diagnostics units, which collectively account for nearly 50% of composite revenue, are amongst the brightest in BDX's portfolio, owing to a rash of significant new product introductions. Such new product launches should have the effect of stimulating BDX's composite organic revenue growth trajectory back above the 6%- range, in our view, which could represent a key multiple expansion catalyst." At the moment, Jefferies has a Buy rating and a price target of $98 placed on the company's stock. On Monday, Becton lost 0.64% of its value to close the day at $85.21.